KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Change in Inventory (2018 - 2025)

Castle Biosciences' Change in Inventory history spans 7 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Change in Inventory rose 2.62% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $2.1 million, up 1009.84%, while the annual FY2025 figure was $2.1 million, 1009.84% up from the prior year.
  • Change in Inventory for Q4 2025 was $1.6 million at Castle Biosciences, up from $307000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.2 million in Q4 2023 and bottomed at -$1.4 million in Q3 2024.
  • The 5-year median for Change in Inventory is $318000.0 (2022), against an average of $382500.0.
  • The largest annual shift saw Change in Inventory surged 1991.67% in 2021 before it crashed 333.0% in 2025.
  • A 5-year view of Change in Inventory shows it stood at -$355000.0 in 2021, then soared by 150.14% to $178000.0 in 2022, then soared by 1120.79% to $2.2 million in 2023, then dropped by 28.07% to $1.6 million in 2024, then rose by 2.62% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Change in Inventory are $1.6 million (Q4 2025), $307000.0 (Q3 2025), and $1.5 million (Q2 2025).